首页> 美国卫生研究院文献>Postpy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology >The relationship between neutrophil to lymphocyte ratio platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention
【2h】

The relationship between neutrophil to lymphocyte ratio platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention

机译:冠心病介入治疗ST段抬高急性心肌梗死患者中性粒细胞与淋巴细胞比例血小板与淋巴细胞比例和溶栓与心肌梗死危险性评分的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThe thrombolysis in myocardial infarction (TIMI) risk score is calculated as the sum of independent predictors of mortality and ischemic events in ST elevation acute myocardial infarction (STEMI). Several studies show that the neutrophil to lymphocyte ratio (NLR) is a prognostic inflammatory marker. In preliminary studies, platelet to lymphocyte ratio (PLR) has been proposed as a pro-thrombotic marker. The relationship between NLR, PLR and TIMI risk score for STEMI has never been studied.
机译:简介心肌梗塞溶栓(TIMI)风险评分的计算方法是ST抬高急性心肌梗死(STEMI)死亡率和缺血事件的独立预测因子之和。多项研究表明,中性粒细胞与淋巴细胞的比率(NLR)是一种预后的炎症指标。在初步研究中,血小板与淋巴细胞的比例(PLR)已被提议作为血栓形成前的标志物。从未研究过STEMI的NLR,PLR和TIMI风险评分之间的关​​系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号